Search research articles
Contact Us
Filters
Showing results (41-50 of 50) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 50 results.
ACS Chemical Biology
|
November 9, 2018
Antagonists for Constitutively Active Mutant Estrogen Receptors: Insights into the Roles of Antiestrogen-Core and Side-Chain
Abhishek Sharma, Weiyi Toy, Valeria Sanabria Guillen, et al.
Nutrients
|
October 27, 2018
Multilevel Structural Equation Modeling of Students' Dietary Intentions/Behaviors, BMI, and the Healthfulness of Convenience Stores
Tanya Horacek, Elif Dede Yildirim, Kendra Kattelmann, et al.
Journal of Nutrition Education and Behavior
|
November 13, 2012
The development and preliminary validation of the behavior, environment, and changeability survey (BECS)
Jennifer R Walsh, Angel Hebert, Carol Byrd-Bredbenner, et al.
Cell
|
May 8, 2021
Neutrophil elastase selectively kills cancer cells and attenuates tumorigenesis
Chang Cui, Kasturi Chakraborty, Xu Anna Tang, et al.
Nature Genetics
|
November 5, 2013
ESR1 ligand-binding domain mutations in hormone-resistant breast cancer
Weiyi Toy, Yang Shen, Helen Won, et al.
Cancer Communications (London, England)
|
January 20, 2023
Dynamic epi-transcriptomic landscape mapping with disease progression in estrogen receptor-positive breast cancer
Stephen Keelan, Mihaela Ola, Sara Charmsaz, et al.
International Journal of Environmental Research and Public Health
|
March 7, 2019
Development and Validation of the Policies, Opportunities, Initiatives and Notable Topics (POINTS) Audit for Campuses and Worksites
Tanya M Horacek, Marlei Simon, Elif Dede Yildirim, et al.
International Journal of Environmental Research and Public Health
|
November 30, 2018
Development and Validation of a Simple Convenience Store SHELF Audit
Tanya M Horacek, Elif Dede Yildirim, Erin Kelly, et al.
Cancer Discovery
|
December 18, 2016
Activating <i>ESR1</i> Mutations Differentially Affect the Efficacy of ER Antagonists
Weiyi Toy, Hazel Weir, Pedram Razavi, et al.
ACS Omega
|
June 16, 2025
Discovery of Palazestrant (OP-1250), a Potent and Orally Bioavailable Complete Estrogen Receptor Antagonist (CERAN) and Selective Estrogen Receptor Degrader (SERD)
Raymond A Ng, Susanna Barratt, Alison Parisian, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 50) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 50 results.
ACS Chemical Biology
|
November 9, 2018
Antagonists for Constitutively Active Mutant Estrogen Receptors: Insights into the Roles of Antiestrogen-Core and Side-Chain
Abhishek Sharma, Weiyi Toy, Valeria Sanabria Guillen, et al.
Nutrients
|
October 27, 2018
Multilevel Structural Equation Modeling of Students' Dietary Intentions/Behaviors, BMI, and the Healthfulness of Convenience Stores
Tanya Horacek, Elif Dede Yildirim, Kendra Kattelmann, et al.
Journal of Nutrition Education and Behavior
|
November 13, 2012
The development and preliminary validation of the behavior, environment, and changeability survey (BECS)
Jennifer R Walsh, Angel Hebert, Carol Byrd-Bredbenner, et al.
Cell
|
May 8, 2021
Neutrophil elastase selectively kills cancer cells and attenuates tumorigenesis
Chang Cui, Kasturi Chakraborty, Xu Anna Tang, et al.
Nature Genetics
|
November 5, 2013
ESR1 ligand-binding domain mutations in hormone-resistant breast cancer
Weiyi Toy, Yang Shen, Helen Won, et al.
Cancer Communications (London, England)
|
January 20, 2023
Dynamic epi-transcriptomic landscape mapping with disease progression in estrogen receptor-positive breast cancer
Stephen Keelan, Mihaela Ola, Sara Charmsaz, et al.
International Journal of Environmental Research and Public Health
|
March 7, 2019
Development and Validation of the Policies, Opportunities, Initiatives and Notable Topics (POINTS) Audit for Campuses and Worksites
Tanya M Horacek, Marlei Simon, Elif Dede Yildirim, et al.
International Journal of Environmental Research and Public Health
|
November 30, 2018
Development and Validation of a Simple Convenience Store SHELF Audit
Tanya M Horacek, Elif Dede Yildirim, Erin Kelly, et al.
Cancer Discovery
|
December 18, 2016
Activating <i>ESR1</i> Mutations Differentially Affect the Efficacy of ER Antagonists
Weiyi Toy, Hazel Weir, Pedram Razavi, et al.
ACS Omega
|
June 16, 2025
Discovery of Palazestrant (OP-1250), a Potent and Orally Bioavailable Complete Estrogen Receptor Antagonist (CERAN) and Selective Estrogen Receptor Degrader (SERD)
Raymond A Ng, Susanna Barratt, Alison Parisian, et al.
Page
of 5